Literature DB >> 66956

Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker.

S I Drew, P I Terasaki, R J Billing, O J Bergh, J Minowada, E Klein.   

Abstract

Group-specific human granulocyte antigens are serologically detectable with granulocytotoxic-positive human alloantisera on a cell line, K562, of chronic myelogenous leukemia origin which bears a Philadelphia chromosomal marker. The same cell line lacks serologically detectable HLA, B2 microglobulin, and B-lymphocyte antigens. Granulocyte antigens are important cell markers for cell lines of suspected myeloid lineage.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 66956

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  10 in total

1.  K562 cells express human major histocompatibility antigens.

Authors:  A Ziegler; D Laudien; H Heinrichs; C Müller; B Uchańska-Ziegler; P Wernet
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

2.  In vitro augmentation of human natural cytotoxic activity.

Authors:  M R Potter; M Moore
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

3.  Expression of epidermal-growth-factor receptor in the K562 cell line by transfection. Altered receptor biochemistry.

Authors:  H Allen; J Hsuan; S Clark; R Maziarz; M D Waterfield; R A Flavell; J Haley
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

4.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

5.  Mechanisms by which human gliomas may escape cellular immune attack.

Authors:  M K Gately; M Glaser; R M McCarron; S J Dick; M D Dick; R W Mettetal; P L Kornblith
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

6.  Cloning and structural characterization of a human non-erythroid band 3-like protein.

Authors:  D R Demuth; L C Showe; M Ballantine; A Palumbo; P J Fraser; L Cioe; G Rovera; P J Curtis
Journal:  EMBO J       Date:  1986-06       Impact factor: 11.598

7.  Isoenzymes of lactate dehydrogenase in human leukemic cells in culture treated with inducers of differentiation.

Authors:  P Pantazis; S A Lazarou; N M Papadopoulos
Journal:  J Cell Biol       Date:  1981-08       Impact factor: 10.539

8.  High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.

Authors:  Sarah M McAlpine; Sarah E Roberts; John J Heath; Fabian Käsermann; Andrew C Issekutz; Thomas B Issekutz; Beata Derfalvi
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

9.  A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus.

Authors:  Z Bösze; H J Thiesen; P Charnay
Journal:  EMBO J       Date:  1986-07       Impact factor: 11.598

10.  Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.

Authors:  S G Gangal; N K Damle; A G Khare; S H Advani
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.